Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex

Cell

Volumn 165, Issue 2, 2016, Pages 331-342

  Shen, Hongjie ^a,b   Xu, Wenqi ^a,b   Guo, Rui ^a   Rong, Bowen ^a   Gu, Lei ^c   Wang, Zhentian ^a   He, Chenxi ^a   Zheng, Lijuan ^a   Hu, Xin ^d   Hu, Zhen ^d   Shao, Zhi Ming ^d   Yang, Pengyuan ^a   Wu, Feizhen ^a   Shi, Yujiang Geno ^a,b,c   Shi, Yang ^a,b,c   Lan, Fei ^a,b,d  

^a FUDAN UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; RACK7 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; KDM5C PROTEIN, HUMAN; PROTEIN S 100; RECEPTORS FOR ACTIVATED C KINASE;

ANIMAL CELL; ARTICLE; BIOCHEMICAL ANALYSIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENHANCER REGION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; ANIMAL; CANCER TRANSPLANTATION; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; XENOGRAFT;

ANIMALS; CARCINOGENESIS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HETEROGRAFTS; HISTONE DEMETHYLASES; HUMANS; MICE; NEOPLASM TRANSPLANTATION; RECEPTORS, CELL SURFACE; S100 PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84964063271     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.02.064     Document Type: Article

References (56)

1. C.E. Antal, A.M. Hudson, E. Kang, C. Zanca, C. Wirth, N.L. Stephenson, E.W. Trotter, L.L. Gallegos, C.J. Miller, F.B. Furnari, and et al. Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor Cell 160 2015 489 502
2. L.P. Blair, J. Cao, M.R. Zou, J. Sayegh, and Q. Yan Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer Cancers (Basel) 3 2011 1383 1404
3. A.R. Bresnick, D.J. Weber, and D.B. Zimmer S100 proteins in cancer Nat. Rev. Cancer 15 2015 96 109
4. C. Buecker, R. Srinivasan, Z. Wu, E. Calo, D. Acampora, T. Faial, A. Simeone, M. Tan, T. Swigut, and J. Wysocka Reorganization of enhancer patterns in transition from naive to primed pluripotency Cell Stem Cell 14 2014 838 853
5. E. Calo, and J. Wysocka Modification of enhancer chromatin: what, how, and why? Mol. Cell 49 2013 825 837
6. K. Chen, Z. Chen, D. Wu, L. Zhang, X. Lin, J. Su, B. Rodriguez, Y. Xi, Z. Xia, X. Chen, and et al. Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes Nat. Genet. 47 2015 1149 1157
7. J. Cheng, R. Blum, C. Bowman, D. Hu, A. Shilatifard, S. Shen, and B.D. Dynlacht A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers Mol. Cell 53 2014 979 992
8. M.P. Creyghton, A.W. Cheng, G.G. Welstead, T. Kooistra, B.W. Carey, E.J. Steine, J. Hanna, M.A. Lodato, G.M. Frampton, P.A. Sharp, and et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state Proc. Natl. Acad. Sci. USA 107 2010 21931 21936
9. G.L. Dalgliesh, K. Furge, C. Greenman, L. Chen, G. Bignell, A. Butler, H. Davies, S. Edkins, C. Hardy, C. Latimer, and et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360 363
10. F. De Santa, I. Barozzi, F. Mietton, S. Ghisletti, S. Polletti, B.K. Tusi, H. Muller, J. Ragoussis, C.L. Wei, and G. Natoli A large fraction of extragenic RNA pol II transcription sites overlap enhancers PLoS Biol. 8 2010 e1000384
11. D.J. Ford, and A.K. Dingwall The cancer COMPASS: navigating the functions of MLL complexes in cancer Cancer Genet. 208 2015 178 191
12. S.C. Fossey, S. Kuroda, J.A. Price, J.K. Pendleton, B.I. Freedman, and D.W. Bowden Identification and characterization of PRKCBP1, a candidate RACK-like protein Mamm. Genome 11 2000 919 925
13. N.J. Fredriksson, L. Ny, J.A. Nilsson, and E. Larsson Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types Nat. Genet. 46 2014 1258 1263
14. T.F. Gonçalves, A.P. Gonçalves, N. Fintelman Rodrigues, J.M. dos Santos, M.M. Pimentel, and C.B. Santos-Rebouças KDM5C mutational screening among males with intellectual disability suggestive of X-Linked inheritance and review of the literature Eur. J. Med. Genet. 57 2014 138 144
15. R. Guo, L. Zheng, J.W. Park, R. Lv, H. Chen, F. Jiao, W. Xu, S. Mu, H. Wen, J. Qiu, and et al. BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing Mol. Cell 56 2014 298 310
16. A.A. Hakimi, Y.B. Chen, J. Wren, M. Gonen, O. Abdel-Wahab, A. Heguy, H. Liu, S. Takeda, S.K. Tickoo, V.E. Reuter, and et al. Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma Eur. Urol. 63 2013 848 854
17. D. Hnisz, B.J. Abraham, T.I. Lee, A. Lau, V. Saint-André, A.A. Sigova, H.A. Hoke, and R.A. Young Super-enhancers in the control of cell identity and disease Cell 155 2013 934 947
18. M. Jung, K.A. Gelato, A. Fernández-Montalván, S. Siegel, and B. Haendler Targeting BET bromodomains for cancer treatment Epigenomics 7 2015 487 501
19. T.K. Kim, M. Hemberg, J.M. Gray, A.M. Costa, D.M. Bear, J. Wu, D.A. Harmin, M. Laptewicz, K. Barbara-Haley, S. Kuersten, and et al. Widespread transcription at neuronal activity-regulated enhancers Nature 465 2010 182 187
20. S.L. Kloet, H.I. Baymaz, M. Makowski, V. Groenewold, P.W. Jansen, M. Berendsen, H. Niazi, G.J. Kops, and M. Vermeulen Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics FEBS J. 282 2015 1774 1785
21. F. Koch, and J.C. Andrau Initiating RNA polymerase II and TIPs as hallmarks of enhancer activity and tissue-specificity Transcription 2 2011 263 268
22. O.I. Koues, R.A. Kowalewski, L.W. Chang, S.C. Pyfrom, J.A. Schmidt, H. Luo, L.E. Sandoval, T.B. Hughes, J.J. Bednarski, A.F. Cashen, and et al. Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma Immunity 42 2015 186 198
23. M.S. Kowalczyk, J.R. Hughes, D. Garrick, M.D. Lynch, J.A. Sharpe, J.A. Sloane-Stanley, S.J. McGowan, M. De Gobbi, M. Hosseini, D. Vernimmen, and et al. Intragenic enhancers act as alternative promoters Mol. Cell 45 2012 447 458
24. F. Lai, U.A. Orom, M. Cesaroni, M. Beringer, D.J. Taatjes, G.A. Blobel, and R. Shiekhattar Activating RNAs associate with Mediator to enhance chromatin architecture and transcription Nature 494 2013 497 501
25. M.T. Lam, W. Li, M.G. Rosenfeld, and C.K. Glass Enhancer RNAs and regulated transcriptional programs Trends Biochem. Sci. 39 2014 170 182
26. F. Lan, and Y. Shi Histone H3.3 and cancer: A potential reader connection Proc. Natl. Acad. Sci. USA 112 2015 6814 6819
27. F. Lan, R.E. Collins, R. De Cegli, R. Alpatov, J.R. Horton, X. Shi, O. Gozani, X. Cheng, and Y. Shi Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression Nature 448 2007 718 722
28. F. Lan, A.C. Nottke, and Y. Shi Mechanisms involved in the regulation of histone lysine demethylases Curr. Opin. Cell Biol. 20 2008 316 325
29. J.-E. Lee, C. Wang, S. Xu, Y.-W. Cho, L. Wang, X. Feng, A. Baldridge, V. Sartorelli, L. Zhuang, W. Peng, and et al. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation eLife 2 2013 e01503
30. T. Liu, J.A. Ortiz, L. Taing, C.A. Meyer, B. Lee, Y. Zhang, H. Shin, S.S. Wong, J. Ma, Y. Lei, and et al. Cistrome: an integrative platform for transcriptional regulation studies Genome Biol. 12 2011 R83
31. J. Lovén, H.A. Hoke, C.Y. Lin, A. Lau, D.A. Orlando, C.R. Vakoc, J.E. Bradner, T.I. Lee, and R.A. Young Selective inhibition of tumor oncogenes by disruption of super-enhancers Cell 153 2013 320 334
32. M.L. Maeder, S.J. Linder, V.M. Cascio, Y. Fu, Q.H. Ho, and J.K. Joung CRISPR RNA-guided activation of endogenous human genes Nat. Methods 10 2013 977 979
33. A. Malovannaya, R.B. Lanz, S.Y. Jung, Y. Bulynko, N.T. Le, D.W. Chan, C. Ding, Y. Shi, N. Yucer, G. Krenciute, and et al. Analysis of the human endogenous coregulator complexome Cell 145 2011 787 799
34. C. Melton, J.A. Reuter, D.V. Spacek, and M. Snyder Recurrent somatic mutations in regulatory regions of human cancer genomes Nat. Genet. 47 2015 710 716
35. N. Mosammaparast, and Y. Shi Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases Annu. Rev. Biochem. 79 2010 155 179
36. A. Mueller, T. Bächi, M. Höchli, B.W. Schäfer, and C.W. Heizmann Subcellular distribution of S100 proteins in tumor cells and their relocation in response to calcium activation Histochem. Cell Biol. 111 1999 453 459
37. X. Niu, T. Zhang, L. Liao, L. Zhou, D.J. Lindner, M. Zhou, B. Rini, Q. Yan, and H. Yang The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C Oncogene 31 2012 776 786
38. H. Ogawa, K. Ishiguro, S. Gaubatz, D.M. Livingston, and Y. Nakatani A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells Science 296 2002 1132 1136
39. N.S. Outchkourov, J.M. Muiño, K. Kaufmann, W.F. van Ijcken, M.J. Groot Koerkamp, D. van Leenen, P. de Graaf, F.C. Holstege, F.G. Grosveld, and H.T. Timmers Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function Cell Rep. 3 2013 1071 1079
40. J. Park, D. Betel, R. Gryfe, K. Michalickova, N. Di Nicola, S. Gallinger, C.W. Hogue, and M. Redston Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites Cancer Res. 62 2002 1284 1288
41. A. Pekowska, T. Benoukraf, J. Zacarias-Cabeza, M. Belhocine, F. Koch, H. Holota, J. Imbert, J.C. Andrau, P. Ferrier, and S. Spicuglia H3K4 tri-methylation provides an epigenetic signature of active enhancers EMBO J. 30 2011 4198 4210
42. J.L. Plank, and A. Dean Enhancer function: mechanistic and genome-wide insights come together Mol. Cell 55 2014 5 14
43. S. Pott, and J.D. Lieb What are super-enhancers? Nat. Genet. 47 2015 8 12
44. P.B. Rasmussen, and P. Staller The KDM5 family of histone demethylases as targets in oncology drug discovery Epigenomics 6 2014 277 286
45. U. Sack, W. Walther, D. Scudiero, M. Selby, J. Aumann, C. Lemos, I. Fichtner, P.M. Schlag, R.H. Shoemaker, and U. Stein S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells Mol. Biol. Cell 22 2011 3344 3354
46. C.S. Schuetz, M. Bonin, S.E. Clare, K. Nieselt, K. Sotlar, M. Walter, T. Fehm, E. Solomayer, O. Riess, D. Wallwiener, and et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis Cancer Res. 66 2006 5278 5286
47. J. Shi, W.A. Whyte, C.J. Zepeda-Mendoza, J.P. Milazzo, C. Shen, J.S. Roe, J.L. Minder, F. Mercan, E. Wang, M.A. Eckersley-Maslin, and et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation Genes Dev. 27 2013 2648 2662
48. K.R. Veeramah, L. Johnstone, T.M. Karafet, D. Wolf, R. Sprissler, J. Salogiannis, A. Barth-Maron, M.E. Greenberg, T. Stuhlmann, S. Weinert, and et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies Epilepsia 54 2013 1270 1281
49. M. Vermeulen, K.W. Mulder, S. Denissov, W.W. Pijnappel, F.M. van Schaik, R.A. Varier, M.P. Baltissen, H.G. Stunnenberg, M. Mann, and H.T. Timmers Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4 Cell 131 2007 58 69
50. D. Wang, I. Garcia-Bassets, C. Benner, W. Li, X. Su, Y. Zhou, J. Qiu, W. Liu, M.U. Kaikkonen, K.A. Ohgi, and et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA Nature 474 2011 390 394
51. F. Wang, C.B. Marshall, and M. Ikura Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition Cell. Mol. Life Sci. 70 2013 3989 4008
52. H. Wen, Y. Li, Y. Xi, S. Jiang, S. Stratton, D. Peng, K. Tanaka, Y. Ren, Z. Xia, J. Wu, and et al. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression Nature 508 2014 263 268
53. W.A. Whyte, S. Bilodeau, D.A. Orlando, H.A. Hoke, G.M. Frampton, C.T. Foster, S.M. Cowley, and R.A. Young Enhancer decommissioning by LSD1 during embryonic stem cell differentiation Nature 482 2012 221 225
54. W.A. Whyte, D.A. Orlando, D. Hnisz, B.J. Abraham, C.Y. Lin, M.H. Kagey, P.B. Rahl, T.I. Lee, and R.A. Young Master transcription factors and mediator establish super-enhancers at key cell identity genes Cell 153 2013 307 319
55. J. Wysocka, T. Swigut, H. Xiao, T.A. Milne, S.Y. Kwon, J. Landry, M. Kauer, A.J. Tackett, B.T. Chait, P. Badenhorst, and et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling Nature 442 2006 86 90
56. M.A. Zabidi, C.D. Arnold, K. Schernhuber, M. Pagani, M. Rath, O. Frank, and A. Stark Enhancer-core-promoter specificity separates developmental and housekeeping gene regulation Nature 518 2015 556 559